NYSE:ARMP | Cash Flow Statement | Armata Pharmaceuticals, Inc.

Complete source-backed cash-flow history.

Available history
2013-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30$74.14M
2026-03-31-$115.35M-$5.78M$63,000.00-$63,000.00$641,000.00
2025-12-31-$124.3M-$6.67M$52,000.00-$52,000.00$658,000.00
2025-09-30-$26.68M
2025-06-30-$16.3M
2025-03-31-$6.53M$377,000.00-$7.58M$99,000.00-$99,000.00$9.99M
2024-12-31$2.6M$380,000.00-$7.93M-$77,000.00$77,000.00$0.00
2024-09-30-$5.48M
2024-06-30$8.99M
2024-03-31-$25.02M$317,000.00-$10.58M$250,000.00-$250,000.00$34.93M
2023-12-31-$19.85M$293,000.00-$8.11M$2.4M-$2.39M-$43,000.00
2023-09-30-$31.16M
2023-06-30-$3.55M
2023-03-31-$14.49M$230,000.00-$17.57M$2.01M-$2.01M$29.59M
2022-12-31-$10.31M-$10.49M-$455,000.00$455,000.00-$500,000.00
2022-09-30-$8.61M
2022-06-30-$9.22M
2022-03-31-$8.77M-$3.52M$236,000.00-$236,000.00$44.63M
2021-12-31-$6.05M-$8.6M$228,000.00-$228,000.00$7.04M
2021-09-30-$5.42M
2021-06-30-$6.19M
2021-03-31-$5.5M-$5.48M$298,000.00-$298,000.00$18.58M
2020-12-31-$6.62M-$6.3M$366,000.00-$366,000.00$432,000.00
2020-09-30-$5.77M
2020-06-30-$4.71M
2020-03-31-$5.08M-$4.23M$104,000.00-$104,000.00$22.41M
2019-12-31-$4.59M-$2.73M$21,000.00$72,000.00$0.00
2019-09-30-$6.96M
2019-06-30-$4.2M
2019-03-31-$3.74M-$2.46M$142,000.00-$142,000.00-$1M
2018-12-31-$1.1M-$3.2M$391,000.00-$535,000.00$6.09M
2018-09-30-$2.77M
2018-06-30-$3.17M
2018-03-31-$3.13M-$3.54M$6.61M
2017-12-31-$2.35M-$2.37M$18,000.00-$18,000.00-$206,000.00
2017-09-30-$779,000.00
2017-06-30-$6.46M
2017-03-31-$3.25M-$3.3M$5,000.00-$5,000.00-$205,000.00
2016-12-31-$9.5M-$1.5M$13,000.00$0.00
2016-09-30-$2.38M
2016-06-30-$3.85M
2016-03-31-$3.11M-$3.09M$112,000.00
2015-12-31-$2.23M-$2.32M$50,000.00
2015-09-30$5.44M
2015-06-30$10.77M
2015-03-31-$14.49M-$2.31M$35,000.00
2014-12-31-$664,000.00-$3.2M$5,000.00
2014-09-30$21.21M
2014-06-30$13.87M
2014-03-31-$11.31M-$3.69M$229,000.00
2013-12-31-$6.25M-$1.39M$5,000.00
2013-09-30-$43.9M
2013-06-30-$12.81M
2013-03-31-$1.62M-$1.01M$0.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$173.8M-$25.76M$542,000.00-$542,000.00$25.61M
2024-12-31-$18.92M$1.33M-$37.55M$1.88M-$1.88M$34.96M
2023-12-31-$69.05M$972,000.00-$47.42M$8.14M-$8.13M$53.99M
2022-12-31-$36.92M$892,000.00-$32.48M$2.21M-$2.21M$44.02M
2021-12-31-$23.16M-$23.58M$1.3M-$1.3M$25.52M
2020-12-31-$22.18M-$18.27M$824,000.00-$824,000.00$23.21M
2019-12-31-$19.48M-$15.58M$224,000.00$2.88M$8.98M
2018-12-31-$16.7M-$10.63M$875,000.00$8.81M$12.45M
2017-12-31-$12.84M-$9.19M$58,000.00-$58,000.00$8.67M
2016-12-31-$18.84M-$10.61M$279,000.00-$279,000.00$80,000.00$7.23M
2015-12-31-$516,000.00-$9.78M$210,000.00
2014-12-31$23.11M-$12.57M$1.2M
2013-12-31-$64.58M-$6.29M$102,000.00